Kratom Testing Update for Florida's 2026 Requirements

Florida's kratom requirements changed on July 1, 2026. The regulatory list below and the current T191 analytical scope are related but not identical. Share the exact product, target market, and reporting objective so the laboratory can confirm whether T191, T814, or another reviewed scope fits the project.

Florida's current compound limits and ratio

Florida Emergency Rule 2ER26-1 took effect July 1, 2026, and is currently scheduled to expire June 30, 2027. It names seven compounds:

1. 7-hydroxymitragynine
2. 9-hydroxycorynantheidine
3. 10-hydroxycorynantheidine
4. Mitragynine pseudoindoxyl
5. 7-acetoxymitragynine
6. Dihydro-7-hydroxymitragynine (MGM-15)
7. 9-fluoro-7-hydroxymitragynine (MGM-16)

The rule sets a 1 mg/g threshold for solid and powdered products, including encapsulated materials, and a 1 mg/mL threshold for liquid products, including beverages, extracts, and tinctures. Products containing one or more of the listed compounds must have at least 100 parts mitragynine by mass for every one part of the listed compounds, individually or combined.

The operative liquid unit is 1 mg/mL. An initial publication used 1 mg/L, but Florida issued a technical correction on July 1, 2026.

FDACS repealed the Florida labeling rule on August 6

The official record for FDACS Emergency Rule 5KER26-9 shows that the rule took effect July 1, 2026 and was repealed effective August 6, 2026. As a result, 5KER26-9 no longer requires its concentration and ratio disclosures on kratom product labels.

In its August 7 repeal explanation, FDACS cited the DEA's July 6 notice of intent to temporarily schedule multiple compounds at concentrations different from those in 2ER26-1. FDACS said it intends to wait before adopting labeling requirements while conditions are changing.

A prior FDACS industry notice described the now-repealed labeling framework and separately stated that FDACS considered 7-acetoxymitragynine, MGM-15, and MGM-16 adulterants under section 500.10, Florida Statutes. The August 7 repeal notice does not say that FDACS withdrew that separate adulteration position. Because this area is changing, obtain current FDACS or legal guidance before relying on the earlier notice.

What changed from the former 400 ppm dry-weight framework

Florida's former rules used a 400 ppm (0.04%) dry-weight threshold for 7-OH and required a dry-weight 7-OH label declaration. The official repeal notice states that the Attorney General repealed Emergency Rule 2ER25-3 on June 23, 2026; FDACS records the related 5KER26-8 labeling rule as repealed in its July 1 notice. The former single-analyte framework therefore is not the operative Florida framework after June 30, 2026.

Effective July 1, 2ER26-1 replaced the former scheduling approach with seven listed compounds, product-form reporting units, and a mitragynine ratio. FDACS separately adopted labeling requirements in 5KER26-9 on July 1, then repealed that labeling rule effective August 6. Accordingly, 2ER26-1 remains current while the 5KER26-9 labeling framework does not.

T191 Kratom Adulterants vs. the T814 Florida Reporting Package

T191 and T814 serve different roles. T191 — Kratom Adulterants is the six-analyte quantitative panel described above. It supplies individual results for the targets in its current scope. T191 does not by itself cover every compound named in 2ER26-1 or provide T814's bundled calculation and reporting table; applicable mitragynine information comes from T102.

The T814 service name describes the package's reporting format; it does not mean that every included output is currently required on a Florida label.

T814 is a panel/reporting part number, not a third analytical method. It does not independently retest the compounds. T814 combines:

• T102 mitragynine concentration and per-unit results
• T191 results for the panel's six named targets
• Applicable mg/g or mg/mL conversions
• Regulated Component Total
• Mitragynine-to-regulated-component Compliance Ratio
• Whole-milligram Alkaloid Ratio Declaration
• The organized table of analytical findings, specifications, calculated labeling values, and applicable PASS/FAIL determinations

These outputs remain available for technical review, internal specifications, customer reporting, or preparation for possible future labeling requirements. They are not currently mandated by 5KER26-9.

For liquid products, an appropriate density result may also be required to convert mass-basis results to mg/mL.

Choosing T191 or T814